9/13
12:10 pm
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
9/13
11:39 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
9/13
11:39 am
phat
Rating for PHAT
Low
Report
Rating for PHAT
9/6
02:02 pm
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
9/6
01:13 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
9/6
01:13 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
8/30
12:16 pm
phat
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
8/30
12:06 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
8/30
12:06 pm
phat
Rating for PHAT
Low
Report
Rating for PHAT
8/23
01:18 pm
phat
Rating for PHAT
Medium
Report
Rating for PHAT
8/23
01:18 pm
phat
Rating for PHAT
Medium
Report
Rating for PHAT